Overview of Multiple Sclerosis Epidemiology
Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis.
Challenges with TNBC Influenced by Racial Disparities
Drs Derek van Amerongen, Soyini Hawkins, Roxie Cannon Wells, and Sharon Deans highlight triple-negative breast cancer among underrepresented patient populations.
Community-Based Screening Initiatives in Women's Health
The panel highlights initiatives to aid women in early cervical cancer diagnosis and intervention.
Social and Clinical Barriers Associated with HIV
An expert panel navigates stigmas and barriers inhibiting patients from achieving optimal care for HIV.
Barriers to Obtaining Optimal HIV Treatment
Dr Adam C. Welch drives a discussion highlighting disparities in health care equity affecting patients who receive an HIV diagnosis.
RSV Outcomes in Infant, Pediatric, and Adult Patient Populations
Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.
Clinical Trials Surrounding Effectiveness of RSV Vaccine
Key opinion leaders discuss ongoing clinical trials for respiratory syncytial virus vaccines.
Clinical Goals for Treating RSV
The panel discusses potential therapy options for adults infected with respiratory syncytial virus.
Collaborative Care and Patient Education Driving AD Treatment Pathways
In their final thoughts, medical experts highlight key considerations in the atopic dermatitis (AD) treatment landscape.
Medication Affordability Impacting AD Treatment Compliance
Amy Brennan underlines the impact of affordability and how it may be inhibiting the patient atopic dermatitis (AD) treatment process.
Cervical and Breast Cancers Affected by Racial Disparities
Key opinion leaders provide insight on the effect of racial disparities on patients with cervical and breast cancer.
Initiatives to Reduce Maternal Mortality: Part 2
Experts expand on racial and social factors influencing maternal mortality.
Payor Considerations for Treatment of HIV
Payor considerations in the treatment of HIV are explored.
HIV Incidence and Prevalence
A panel of experts open a discussion surrounding the current disease landscape of HIV.
Financial Considerations in RRMM Treatment Landscape
In their closing thoughts, the panelists discuss financial considerations for treating patients with RRMM.
Establishing Adequate Patient Support Systems
Building strong support systems from both clinical and personal perspectives can drive optimal patient outcomes.
Barriers to Appropriate RRMM Care
Barriers to sufficient multiple myeloma treatment are explored.
Financial Burden Associated with RSV
Financial impacts associated with respiratory syncytial virus infection are highlighted.
Increasing Awareness of RSV Vaccines
Dr Welch leads a conversation regarding strategies to increase awareness of respiratory syncytial virus.
RSV Incidence and Prevalence
Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.
Navigating Prior Authorization and Prescription Process for AD Treatment
Expert panelists discuss bridging communication between payers and providers in the AD treatment pathway.
Patients Seeking AD Treatment Finding Value in White-Glove Service of Local Pharmacies
White-glove service provided by local pharmacies can increase convenience for patients navigating atopic dermatitis (AD) treatment options.
Initiatives to Reduce Maternal Mortality: Part 1
Sharon Deans, MD, MPH, MBA, and Roxie Cannon Wells, MD, discuss disparities affecting maternal mortality rates.
Disparities Related to Morbidity and Mortality in Maternal Health
Ensuring appropriate pre-pregnancy through postnatal care is critical for optimal health of mother and child.
Examining Cytokine Release Syndrome
Cytokine release syndrome can limit aggressive RRMM treatment strategies.
RRMM Treatment Regimen Considerations
Panelists discuss relapsed/refractory multiple myeloma treatment regimen strategies.
Overview of Current Vaccine Landscape
The panel measures the significance of an RSV vaccine in relation to other vaccines in circulation.
Populations At Risk for Contracting RSV
Traditionally thought of as a pediatric disease, RSV also affects older patient populations.
Patient-Specific Characteristics Driving AD Treatment Regimen
Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
JAK Inhibitor Usage Benefiting an Array of Dermatological Conditions
Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.
